Clin2
NCT00162474Worth exploringRecruiting

Study of factors that affect warfarin treatment

Healthy

Treatments studied

This study looks at why some people process warfarin (a blood-thinning medicine) differently. It aims to learn what personal or medication factors may affect how well warfarin works, so future dosing can be safer and more accurate.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
20 years to 50 years
Study type
Interventional

Who can take part

  • Be between 20 and 50 years old
  • Have no major or significant health problems
  • Do not have an allergy to warfarin or phenytoin
  • Do not have an allergy to penicillin or cephalosporin antibiotics (including dicloxacillin)
  • Do not take regular medicines, including birth control pills

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07269301Recruiting· Phase 1
Liver function and study drug processing

This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.

Lake Forest, California
NCT05176379Recruiting· Phase 4
Testing a factor for blood vessel control in healthy adults

This study looks at how a naturally occurring “blood-vessel control” factor affects blood vessel function, mainly in people who are otherwise healthy. It’s likely aimed at understanding normal vascular control and whether the factor changes how blood flow is regulated.

Norman, Oklahoma
NCT02972385Recruiting
Testing how genes affect warfarin dosing in Hispanic and Latino adults

This study looks at how a person’s genes may affect how they respond to warfarin, a blood-thinner, so dosing can be safer and more accurate. It specifically focuses on Hispanic and Latino adults.

Tucson, Arizona
NCT06789588Enrolling by invitation· Phase 3
Better warfarin therapy for atrial fibrillation

This study tests a better way to manage warfarin (a blood thinner) for people with atrial fibrillation (an irregular heartbeat). The goal is to improve treatment and help prevent stroke.

Recife, Pernambuco
NCT06648837Not yet recruiting
Blood donation study for warfarin patients

This study collects blood samples from people who take warfarin to help improve monitoring of the medication. It is designed for patients who are stable on warfarin and want to contribute to research.

Oxford, Oxfordshire
NCT06645275Not yet recruiting· Phase 4
New bedside test to guide warfarin dosing for heart patients

This study tests whether a new bedside test (point-of-care testing) can help doctors give you the right dose of warfarin more quickly and safely. If you are starting warfarin for the first time and are in the hospital for a heart problem, you may be eligible.

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.